The lab is looking for two molecular biologists to work on the development of diagnostic assays for COVID 19/FLU and plant pathogens.

Two post-doc positions available. Look at the News section for more.

Extensive article in press regarding new test, EU funding and spin-out company, all related to Biosenosr lab. Further info in the relevant press release.

Biosensors lab was the recipient of significant European funding (2.3M€ in total) obtained under the emergency action for SARS-CoV-2 outbreak. The work, which will be coordinated by FORTH and includes 7 more partners, was one of the 23 proposals selected for funding from a total of 454 submitted ones.

Biosensors lab coordinates a consortium of 8 partners, which received funding to develop, validate and bring to the market a molecular diagnostic platform to detect COVID-19 and FLU

ΒημαScience publishes an extensive interview of Prof. Gizeli regarding work performed in her group for the developmen of a molecular diagnostic device (IRIS) and assay for COVID-19; the work is now under exploitation through spin-of company BIOPIX-T.

Our new preprint, Real-time colorimetric LAMP methodology for quantitative nucleic acids detection at the point-of-care, can be found here.

“Real-time colorimetric LAMP methodology for quantitative nucleic acids detection at the point-of-care”

3D-printed bioreactors for DNA amplification: application to companion diagnostics accepted for publication in Sensors and Actuators B (available online: 21 April 2020)

“3D-printed bioreactors for DNA amplification: application to companion diagnostics” accepted for publication in Sensors and Actuators B